42. Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, et al. (2008) Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathogens 4: e1000189. 43. Tuve S, Wang H, Ware C, Liu Y, Gaggar A, et al. (2006) A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol 80: 12109–12120. 44. Wu E, Trauger SA, Pache L, Mullen TM, Von Seggern DJ, et al. (2004) Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. . J Virol 78: 3897–3905. 45. Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, et al. (2001) Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 75: 8772–8780. 46. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G (2000) Heparan sulfate glycosaminoglycans are involved in adenovirus type 5- and 2-host cell interactions. Virology 268: 382–390. 47. Gaden F, Franqueville L, Hong SS, Legrand V, Figarella C, et al. (2002) Mechanism of restriction of normal and cystic fibrosis transmembrane conductance regulator-deficient human tracheal gland cells to adenovirus (Ad) infection and Ad-mediated gene transfer. Am J Respir Cell Mol Biol 27: 628–640. 48. Vive`s RR, Lortat-Jacob H, Chroboczek J, Fender P (2004) Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron. Virology 321: 332–340. 49. Vives RR, Sadir R, Imberty A, Rencurosi A, Lortat-Jacob H (2002) A kinetics and modeling study of RANTES(9–68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41: 14779–14789. 50. Bayo-Puxan N, Cascallo M, Gros A, Huch M, Fillat C, et al. (2006) Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J Gen Virol 87: 2487–2495. 51. Kritz AB, Nicol CG, Dishart KL, Nelson R, Holbeck S, et al. (2007) Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop. Mol Ther 15: 741–749. 52. Rezaie AR (2000) Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem 275: 3320–3327. 53. Murakami S, Sakurai F, Kawabata K, Okada N, Fujita T, et al. (2007) Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells. Gene Ther 14: 1525–1533. 54. Nemerow GR, Stewart PL (1999) Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 63: 725–734. 55. Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR (1996) Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 70: 4502–4508. 56. Kawakami Y, Li H, Lam JT, Krasnykh V, Curiel DT, et al. (2003) Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res 63: 1262–1269. 57. Miyazawa N, Crystal RG, Leopold PL (2001) Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J Virol 75: 1387–1400. 58. Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, et al. (1999) Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol 73: 6056–6065. 59. Myhre S, Henning P, Granio O, Tylo AS, Nygren PA, et al. (2007) Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector. Gene Ther 14: 376–381. 60. Nanda A, Lynch DM, Goudsmit J, Lemckert AA, Ewald BA, et al. (2005) Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector- based vaccines in mice and rhesus monkeys. J Virol 2005 Nov;79(22):14161-8 79: 14161–14168. 61. Chiu CY, Wu E, Brown SL, Von Seggern DJ, Nemerow GR, et al. (2001) Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J Virol 75: 5375–5380. 62. Di Paolo NC, Kalyuzhniy O, Shayakhmetov DM (2007) Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo. J Virol 81: 12249–12259. 63. Schoggins JW, Gall JG, Falck-Pedersen E (2003) Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J Virol 77: 1039–1048. 64. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A (1997) Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 71: 4782–4790. 65. Toyoda E, Doi R, Kami K, Mori T, Ito D, et al. (2008) Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells. Int J Oncol 33: 1141–1147. 66. Von Seggern DJ, Huang S, Fleck SK, Stevenson SC, Nemerow GR (2000) Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol 74: 354–362. 67. Zabner J, Chillon M, Grunst T, Moninger TO, Davidson BL, et al. (1999) A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. J Virol 73: 8689–8695. 68. Granio O, Ashbourne Excoffon KJ, Henning P, Melin P, Norez C, et al. (2010) Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the Cellular Trafficking of FX-Ad5fiber35 Complex cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia. Hum Gene Ther 21: 251–269. 69. Darr S, Madisch I, Hofmayer S, Rehren F, Heim A (2009) Phylogeny and primary structure analysis of fiber shafts of all human adenovirus types for rational design of adenoviral gene-therapy vectors. J Gen Virol 90: 2849–2854. 70. Gaden F, Franqueville L, Magnusson MK, Hong SS, Merten MD, et al. (2004) Gene transduction and cell entry pathway of fiber-modified Adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. J Virol 78: 7227–7247. 71. Colin M, Mailly L, Roge´e S, D’Halluin J-C (2005) Efficient species C HAdV infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/ caveola endocytic route. Mol Ther 11: 224–236. 72. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles : artefacts no more. Trends Cell Biol 19: 43–51. 73. Greber UF, Willetts M, Webster P, Helenius A (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477–486. 74. Falco´ n-Pe´rez JM, Nazarian R, Sabatti C, Dell’Angelica EC (2005) Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J Cell Sci 118: 5243–5255. 75. Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. . Nat Biotechnol 12: 1567–1572. 76. Mairhofer M, Steiner M, Salzer U, Prohaska R (2009) Stomatin-like protein-1 interacts with stomatin and is targeted to late endosomes. J Biol Chem 284: 29218–29229. 77. Fender P, Schoehn G, Foucaud-Gamen J, Gout E, Garcel A, et al. (2003) Adenovirus dodecahedron allows large multimeric protein transduction in human cells. J Virol 77: 4960–4964. 78. Fender P, Ruigrok RW, Gout E, Buffet S, Chroboczek J (1997) Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol 15: 52–56. 79. Fender P, Schoehn G, Perron-Sierra F, Tucker GC, Lortat-Jacob H (2008) Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle. Virology 371: 155–164. 80. van den Berg BM, Vink H, Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92: 592–594. 81. Shayakhmetov DM, Li ZY, Ternovoi V, Gaggar A, Gharwan H, et al. (2003) The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol 77: 3712–3723. 82. Shayakhmetov DM, Lieber A (2000) Dependence of adenovirus infectivity on length of the fiber shaft domain. J Virol 74: 10274–10286. 83. Uil TG, de Vrij J, Vellinga J, Rabelink MJ, Cramer SJ, et al. (2009) A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers. J Gene Med 11: 990–1004. 84. Devaux P, Loveland B, Christiansen D, Milland J, D. G (1996) Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J Gen Virol. pp 1477–1481. 85. Franqueville L, Henning P, Magnusson MK, Vigne E, Schoehn G, et al. (2008) Protein crystals in adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS One 3: e2894. 86. Henning P, Andersson KME, Frykholm K, Ali A, Magnusson MK, et al. (2005) Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains. Gene Ther 12: 211–224. 87. Henning P, Lundgren E, Carlsson M, Frykholm K, Johannisson J, et al. (2006) Adenovirus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation. J Gen Virol 87: 3151–3160. 88. Henning P, Magnusson MK, Gunneriusson E, Hong SS, Boulanger P, et al. (2002) Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum Gene Ther 13: 1427–1439. 89. Hong SS, Magnusson MK, Henning P, Lindholm L, Boulanger PA (2003) Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity. Mol Ther 7: 692–699. 90. Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, et al. (2007) Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu. Cancer Gene Ther 14: 1–12. 91. Magnusson MK, Hong SS, Boulanger P, Lindholm L (2001) Genetic retargeting of adenovirus: novel strategy employing ‘‘deknobbing’’ of the fiber. J Virol 75: 7280–7289. 92. Magnusson MK, Hong SS, Henning P, Boulanger P, Lindholm L (2002) Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J Gene Med 4: 356–370. 93. Waszak P, Franqueville L, Franco-Motoya M-L, Rosa-Calatrava M, Boucherat O, et al. (2007) Toxicity of fiber- and penton base-modified adenovirus type 5 vectors on lung development in newborn rats. Mol Ther 15: 2008–2016. 94. Defer C, Belin M-T, Caillet-Boudin M-L, Boulanger P (1990) Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol 64: 3661–3673. 95. Granio O, Porcherot M, Corjon S, Kitidee K, Henning P, et al. (2009) Improved adenovirus type 5 vector-mediated transduction of resistant cells by PLoS ONE | www.plosone.org 18 May 2011 | Volume 6 | Issue 5 | e18205